Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States.
Leah J McGrathRohini K HernandezRobert OvermanDiane ReamsAlexander LiedeM Alan BrookhartElizabeth O'DonnellPublished in: Cancer medicine (2018)
Many patients with NDMM do not initiate IV BPs, particularly those with renal complications. Interruptions of IV BPs were common.